Abstract
Keywords
Misoprostol Tranexamic Acid Postpartum hemorrhage Cesarean section میزوپزوستول ترانگزامیک اسید خونریزی پس از زایمان سزارین
References
-
1.
Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving Mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. the eighth report of the confidential enquiries into maternal deaths in the united kingdom. BJOG 2011; 118: 1-203.
-
2.
F. Gary Cunningham M, Kenneth J. Leveno, MD, Steven L. Bloom, MD, Catherine Y. Spong, MD, Jodi S. Dashe, MD, Barbara L. Hoffman, MD, Brian M. Casey, MD, Jeanne S. Sheffield, MD. Williams Obstetrics, McGraw-Hill's Access Medicine. 24 ed. New York, N.Y.: McGraw Hill Medical; 2014.
-
3.
Chelmow D. Postpartum haemorrhage: prevention. BMJ clinical evidence 2011/04/06 ed2011.
-
4.
Tunalp O, Souza JP, Glmezoglu M. New WHO recommendations on prevention and treatment of postpartum hemorrhage. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 2013; 123: 254-256.
-
5.
Smith HJ, Colvin CJ, Richards E, Roberson J, Sharma G, Thapa K, Gulmezoglu AM. Programmes for advance distribution of misoprostol to prevent post-partum haemorrhage: a rapid literature review of factors affecting implementation. Health policy Plan 2016; 31: 102-113.
-
6.
Esteves-Pereira AP, Deneux-Tharaux C, Nakamura-Pereira M, Saucedo M0, Bouvier-Colle MH, Leal Mdo C. Caesarean delivery and postpartum maternal mortality: a population-based case control study in Brazil. PLoS One 2016; 11: e0153396.
-
7.
Maroufizadeh S, Bagheri Lankarani N, Esmailzadeh A, Almasi-Hashiani A, Amini P, Sepidarkish M, et al. Prevalence of cesarean section and its related factors among multiparous in Tehran province, Iran. Koomesh 2017; 19: 742-748. (Persian).
-
8.
Almasi-Hashiani A, Sepidarkish M, Omani-Samani R. Relationship of gestational weight gain with cesarean delivery risk, low birth weight and preterm labor in underweight women. Koomesh 2018; 20: 7-14. (Persian).
-
9.
Chaudhuri P, Mandi S, Mazumdar A. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery. J Obstet Gynaecol Res 2014; 40: 2023-2030.
-
10.
Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. The Cochrane Database Syst Rev 2007; 3: Cd000494.
-
11.
Eftekhari N, Doroodian M, Lashkarizadeh R. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section. J Obstet Gynaecol 2009; 29: 633-636.
-
12.
Chaudhuri P, Banerjee GB, Mandal A. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss. Int J Gynaecol Obstet 2010; 109: 25-29.
-
13.
Owonikoko KM, Arowojolu AO, Okunlola MA. Effect of sublingualmisoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial. J Obstet Gynaecol Res 2011; 37: 715-721.
-
14.
Conde-Agudelo A, Nieto A, Rosas-Bermudez A, Romero R. Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and metaanalysis. Am J Obstet Gynecol 2013; 209: 40.e1-.e17.
-
15.
Hua J, Chen G, Xing F, Scott M, Li Q. Effect of misoprostol versus oxytocin during caesarean section: a systematic review and meta-analysis. BJOG 2013; 120: 531-540.
-
16.
Kundodyiwa TW, Majoko F, Rusakaniko S. Misoprostol versus oxytocin in the third stage of labor. Int J Gynaecol Obstet 2001; 75: 235-241.
-
17.
Baskett TF, Persad VL, Clough HJ, Young DC. Misoprostol versus oxytocin for the reduction of postpartum blood loss. Int J Gynaecol Obstet 2007; 97: 2-5.
-
18.
Patted SS, Goudar SS, Naik VA, Bellad MB, Edlavitch SA, Kodkany BS, et al. Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a community-based randomised controlled trial in rural India. J Matern Fetal Neonatal Med 2009; 22: 24-28.
-
19.
Gandhi R, Evans HM, Mahomed SR, Mahomed NN. Tranexamic Acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184.
-
20.
Hutton B, Joseph L, Fergusson D, Mazer CD, Shapiro S, Tinmouth A. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. BMJ 2012; 345: e5798.
-
21.
Roberts I, Shakur H, Ker K, Coats T. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2012; 12: Cd004896.
-
22.
Heesen M, Bohmer J, Klohr S, Rossaint R, van de Velde M, Dudenhausen JW, Straube S. Prophylactic tranexamic acid in parturients at low risk for post-partum haemorrhage: systematic review and meta-analysis. Acta Anaesthesiol Scand 2014; 58: 1075-1085.
-
23.
Hutton B, Joseph L, Fergusson D, Mazer CD, Shapiro S, Tinmouth A. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. BMJ 2012; 345: e5798.
-
24.
Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009; 9: 29.
-
25.
Novikova N, Hofmeyr GJ. Tranexamic Acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2010; 7: Cd007872.
-
26.
Peitsidis P, Kadir RA. Antifibrinolytic therapy with Tranexamic Acid in pregnancy and postpartum. Expert Opin Pharmacother 2011; 12: 503-516.
-
27.
Faraoni D, Carlier C, Samama CM, Levy JH, Ducloy-Bouthors AS. [Efficacy and safety of Tranexamic Acid administration for the prevention and/or the treatment of post-partum haemorrhage: a systematic review with meta-analysis]. Ann Fr Anesth Reanim 2014; 33: 563-571.
-
28.
Garrigue A, Pierre F. [Misoprostol: off-label use in the treatment of post-partum hemorrhage]. J Gynecol Obstet Biol Reprod (Paris) 2014; 43: 179-189.
-
29.
Soleimani z, Aghazadeh Naini A. The effectiveness of sublingual misoprostol in prevention of bleeding during cesarean delivery. Iran J Obstet Gynecol Infert 2014; 17: 1-7. (Persian).
-
30.
Sahhaf F, Abbasalizadeh S, Ghojazadeh M, Velayati A, Khandanloo R, Saleh P, et al. Comparison effect of intravenous Tranexamic Acid and misoprostol for postpartum haemorrhage. Niger Med J 2014; 55: 348-353.
-
31.
McClure EM, Jones B, Rouse DJ, Griffin JB, Kamath-Rayne BD, Downs A, Goldenberg RL. Tranexamic acid to reduce postpartum hemorrhage: A MANDATE systematic review and analyses of impact on maternal mortality. Am J Perinatol 2015; 32: 469-474.